Melman Arnold MD entered the industry of Commercial Medical Research in 2000 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Arnold Melman by calling (212) 639-1561 during business hours. You can also write to the business’ Single Location at 111 East 210th St, Bronx, New York NY 10467. You can also visit the company’s website at ionchannelinnovations.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Melman Arnold MD |
Representative: | Arnold Melman |
Place of Business: | 111 East 210th St, Bronx, NY 10467 |
Contact Number: | (212) 639-1561 |
Website: | ionchannelinnovations.com |
Type of Service: | Commercial Medical Research |
SIC Number: | 8731 |
NAICS Number: | 6211110 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2000 |
Income/Year: | $500.000 to $999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Melman Arnold MD is a company operating from Bronx, New York providing professional Commercial Medical Research and relevant B2B variables. It was founded in 2000 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 6211110 as Commercial Medical Research.
With a current employee count of 1 to 4, Melman Arnold MD has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Arnold Melman at (212) 639-1561 for related queries, or to locate its Single Location using the coordinates 40.87988,-73.88028.
The Single Location can also be found at the street address 111 East 210th St in Bronx, New York 10467 and can be engaged online through the company website at ionchannelinnovations.com, the company Twitter , and Facebook page .